Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Keio University
Age
18–69
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Clinical diagnosis of aggressive non-Hodgkin's lymphoma
Refractory to the first line chemotherapy or relapsed
Expression of CD20 on lymphoma cells
Measurable lesions on imaging studies
You may not be if
Blood cell counts not reaching to 3,000/microliter for white blood cells, 7 g/dl for hemoglobin, and 50,000/microliter for platelets without transfusion at the time of registration
Circulating lymphoma cells equal to or more than 25,000/microliter
